Pacific Shuanglin Bio pharmacy Co Ltd Capital Reinvestment Ratio
Pacific Shuanglin Bio pharmacy Co Ltd capital reinvestment ratio. Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Capital Reinvestment Ratio of 1.03x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥70.28 Million) in capital expenditures (CN¥72.17 Million). See Pacific Shuanglin Bio pharmacy Co Ltd (000403) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Pacific Shuanglin Bio pharmacy Co Ltd (2000–2024)
Capital reinvestment ratio of Pacific Shuanglin Bio pharmacy Co Ltd from 2000 to 2024. This chart tracks Pacific Shuanglin Bio pharmacy Co Ltd's Capital Reinvestment Ratio across 21 annual periods. See 000403 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Pacific Shuanglin Bio pharmacy Co Ltd Capital Reinvestment Ratio by Year (2000–2024)
Pacific Shuanglin Bio pharmacy Co Ltd capital reinvestment ratio by year from 2000 to 2024. For the full cash flow conversion analysis, see Pacific Shuanglin Bio pharmacy Co Ltd cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.62x | CN¥321.79 Million | CN¥520.71 Million | ▲ +191.2% |
| 2023 | 0.56x | CN¥679.01 Million | CN¥377.27 Million | ▼ -23.1% |
| 2022 | 0.72x | CN¥524.22 Million | CN¥378.64 Million | ▼ -9.6% |
| 2021 | 0.80x | CN¥408.22 Million | CN¥326.16 Million | ▲ +287.4% |
| 2020 | 0.21x | CN¥194.84 Million | CN¥40.18 Million | ▼ -4.3% |
| 2019 | 0.22x | CN¥190.84 Million | CN¥41.11 Million | ▼ -28.3% |
| 2018 | 0.30x | CN¥116.63 Million | CN¥35.02 Million | ▼ -80.9% |
| 2016 | 1.57x | CN¥62.49 Million | CN¥98.03 Million | ▲ +85.7% |
| 2015 | 0.84x | CN¥70.31 Million | CN¥59.39 Million | ▼ -8.4% |
| 2014 | 0.92x | CN¥77.04 Million | CN¥71.05 Million | ▼ -48.5% |
| 2013 | 1.79x | CN¥91.01 Million | CN¥162.99 Million | ▲ +22.4% |
| 2012 | 1.46x | CN¥123.24 Million | CN¥180.28 Million | ▲ +158.7% |
| 2011 | 0.57x | CN¥130.14 Million | CN¥73.58 Million | ▼ -84.7% |
| 2010 | 3.69x | CN¥9.88 Million | CN¥36.46 Million | ▲ +487.4% |
| 2009 | 0.63x | CN¥111.86 Million | CN¥70.29 Million | ▲ +8.0% |
| 2008 | 0.58x | CN¥74.90 Million | CN¥43.59 Million | ▲ +776.6% |
| 2007 | 0.07x | CN¥95.03 Million | CN¥6.31 Million | ▼ -53.2% |
| 2005 | 0.14x | CN¥49.06 Million | CN¥6.95 Million | ▼ -74.7% |
| 2002 | 0.56x | CN¥159.18 Million | CN¥89.09 Million | ▼ -29.2% |
| 2001 | 0.79x | CN¥111.28 Million | CN¥87.96 Million | ▼ -61.8% |
| 2000 | 2.07x | CN¥27.36 Million | CN¥56.62 Million | — |